• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合并躯体疾病患者的抑郁症管理

Management of depression in patients with coexisting medical illness.

作者信息

Nesse R E, Finlayson R E

机构信息

Mayo Clinic, Rochester, Minnesota, USA.

出版信息

Am Fam Physician. 1996 May 1;53(6):2125-33.

PMID:8623724
Abstract

Depressive illness is common in the general population, with a prevalence of 5 percent. However, 10 to 15 percent of any general medical population has clinically significant depression; in patients with selected chronic illnesses, prevalence rates between 25 to 50 percent are noted. In patients with coexisting medical illness, the diagnosis of depression requires differentiating symptoms of the medical illness from symptoms of the comorbid depression. The Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) can be helpful in this endeavor. An understanding of the effect of particular medications on neurotransmitters is required and can guide the clinician in selecting therapeutic agents that have a low incidence of side effects and toxicity.

摘要

抑郁症在普通人群中很常见,患病率为5%。然而,在任何普通内科人群中,10%至15%的人患有具有临床意义的抑郁症;在患有特定慢性疾病的患者中,患病率在25%至50%之间。对于患有合并内科疾病的患者,抑郁症的诊断需要区分内科疾病的症状和共病抑郁症的症状。《精神疾病诊断与统计手册》(第四版)(DSM-IV)在这方面可能会有所帮助。需要了解特定药物对神经递质的影响,这可以指导临床医生选择副作用和毒性发生率低的治疗药物。

相似文献

1
Management of depression in patients with coexisting medical illness.合并躯体疾病患者的抑郁症管理
Am Fam Physician. 1996 May 1;53(6):2125-33.
2
Evidence report on the occurrence, assessment, and treatment of depression in cancer patients.癌症患者抑郁症的发生、评估及治疗的证据报告
J Natl Cancer Inst Monogr. 2004(32):32-9. doi: 10.1093/jncimonographs/lgh026.
3
Depression and chronic medical illness.抑郁症与慢性疾病。
J Clin Psychiatry. 1990 Jun;51 Suppl:3-11; discussion 12-4.
4
The costs of depression: direct and indirect; treatment versus nontreatment.抑郁症的代价:直接和间接的;治疗与不治疗。
J Clin Psychiatry. 1998;59 Suppl 20:11-4.
5
The influence of comorbid chronic medical conditions on the adequacy of depression care for older Americans.共病慢性疾病对美国老年人抑郁症护理充分性的影响。
J Am Geriatr Soc. 2005 Dec;53(12):2178-83. doi: 10.1111/j.1532-5415.2005.00511.x.
6
Depressive disorders and comorbidity: somatic illness vs. side effect.抑郁症与共病:躯体疾病与副作用
Psychiatr Danub. 2009 Sep;21(3):391-8.
7
Improving depression outcomes in older adults with comorbid medical illness.改善患有合并症的老年成年人的抑郁症治疗效果。
Gen Hosp Psychiatry. 2005 Jan-Feb;27(1):4-12. doi: 10.1016/j.genhosppsych.2004.09.004.
8
The underrecognition and undertreatment of depression: what is the breadth and depth of the problem?抑郁症的认识不足与治疗不足:问题的广度和深度如何?
J Clin Psychiatry. 1999;60 Suppl 7:4-9; discussion 10-1.
9
Diagnosis and treatment of depression in late life.老年期抑郁症的诊断与治疗
J Clin Psychiatry. 1998;59 Suppl 4:80-91.
10
Diagnostic dilemmas presented by patients with anxiety and depression.
Am J Med. 1995 Mar;98(3):278-84. doi: 10.1016/S0002-9343(99)80375-1.

引用本文的文献

1
A European Research Agenda for Somatic Symptom Disorders, Bodily Distress Disorders, and Functional Disorders: Results of an Estimate-Talk-Estimate Delphi Expert Study.一项关于躯体症状障碍、身体困扰障碍和功能障碍的欧洲研究议程:一项“预估-讨论-预估”德尔菲专家研究的结果
Front Psychiatry. 2018 May 14;9:151. doi: 10.3389/fpsyt.2018.00151. eCollection 2018.
2
Depression and loneliness in Jamaicans with sickle cell disease.镰状细胞病患者的抑郁和孤独感。
BMC Psychiatry. 2010 Jun 7;10:40. doi: 10.1186/1471-244X-10-40.
3
Fluoxetine: a review of its therapeutic potential in the treatment of depression associated with physical illness.
氟西汀:关于其治疗与躯体疾病相关抑郁症的治疗潜力综述
Drugs. 2001;61(1):81-110. doi: 10.2165/00003495-200161010-00010.
4
Awareness, diagnosis, and treatment of depression.抑郁症的认知、诊断与治疗。
J Gen Intern Med. 1999 Sep;14(9):569-80. doi: 10.1046/j.1525-1497.1999.03478.x.
5
Risks and benefits of selective serotonin reuptake inhibitors in the treatment of depression.选择性5-羟色胺再摄取抑制剂治疗抑郁症的风险与益处
Drug Saf. 1998 Jan;18(1):57-82. doi: 10.2165/00002018-199818010-00005.